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Supplementary Figure 1. Extended heat map showing associations of significant loci 






Caption for Supplementary Figure 1 (previous page): 
The effect estimates of the associations between significant variants with all lipid metabolites in PROMIS are 
plotted as a heat map. Results are shown for the association of all lipid metabolites (rows) with the most strongly 
associated genetic variant within each locus (columns). The associations with major lipids from the GLGC (total 
cholesterol, HDL-C, LDL-C, and triglycerides), DIAGRAM Consortium (type 2 diabetes), and CARDIoGRAMplusC4D 
Consortium (coronary artery disease) are also shown. The magnitude and direction of the effect estimates 
(standardised per 1-SD) are indicated by a colour scale, with blue indicating a negative association and red 
indicating a positive association with respect to the SNP effect on the trait. Asterisks indicates the degree of 
significance of the P-values of association. * = P < 1 x 10-4; ** = P < 5 x 10-8; *** = P < 8.9 x 10-10. Note: A 









n = 5,662 participants from PROMIS. (a) Number of significantly associated loci per lipid. 
(b) Number of conditionally significant associations within each lipid QTL. (c) Histogram of 














Supplementary Figure 4. Number of lipids in PROMIS associated with each variant 
 
 
Results are shown for the number of lipids in PROMIS associated with each variant at genome-wide significance (P < 8.9 x 10-10). 
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Increased de novo lipogenesis in lipodystrophy patients (left panel based on Eiden et al 
2015) [49] and NAFLD patients (right panel based on Sanders et al 2018) [50] both show 
an increase in TAG(48:1) and TG(50:1) originating from the liver, leading to lower levels 








The flow diagram shows how the “bottom-up” and “top-down” approaches were used and then integrated to identify probable causal genes for each 
significantly associated variant. A proxy is defined as those variants with r2 ≥ 0.8 with the lead (EUR population, 1000 Genomes). Abbreviations: eQTL 
= Expression Quantitative Trait Locus; GO = Gene Ontology; GTEx = Genotype-Tissue Expression; KEGG = Kyoto Encyclopedia of Genes and Genomes; 




Supplementary Figure 7. Association of lipids in PROMIS with significantly associated 
















































































































































Forest plots showing the association of the top 20 most significantly associated lipids in PROMIS with 
the lead variant in each significant locus from the conditional analyses. Note: * = P < 0.001; ** = 
P < 5 x 10-8; *** = P < 8.9 x 10-10. 
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Comparison of –log10 P-values in PROMIS from conditional analyses (pre-adjustment) and after adjustment for several clinical lipid measures 
(total cholesterol, HDL cholesterol, and triglycerides). Association estimates are shown coloured by (a) lipid subclass and (b) genetic locus. 
